A researcher at Tel Aviv University’s Sackler School of Medicine has developed, in conjunction with the drug company Obecure, what could be a new weight-loss wonder drug, which not only quells the desire to consume fatty foods, but also has fewer side effects.
The new drug, called HistaleanTM, is based on betahistine, and is believed that betahistine works by suppressesing the desire to consume fatty foods. The Histalean effects have been found more prominent in women

No User Responded In This Post
Leave Your Comments Here...